ArticleInternational journal of cardiology. Cardiovascular risk and prevention2025
Hypertension control in resource-constrained settings: Bridging socioeconomic gaps with predictive insights.
Article in International journal of cardiology. Cardiovascular risk and prevention, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Development of Natural Colorant-Loaded Oleogels and Their Use in Cookies.Foods (Basel, Switzerland) · 2026Article
- Quality-of-care of Filipino patients with hypertension in primary care settings.BMC primary care · 2026Article
- Hypertension as a Major Risk Factor in Alzheimer's Disease: Mechanisms, Interactions and Therapeutic Perspectives.Clinical interventions in aging · 2026Review
- Letter to the editor: Reassessing predictive models for hypertension control in resource-constrained settings.International journal of cardiology. Cardiovascular risk and prevention · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hypertension continues to be a pivotal driver of global cardiovascular disease burden and adverse health outcomes, particularly in resource-constrained settings where disparities in socioeconomic status and clinical infrastructure hinder effective management. Despite medical advancements, achieving optimal blood pressure (BP) control remains a formidable challenge, necessitating a nuanced understanding of multifactorial risk determinants. Methods: A cross-sectional analysis was conducted on 1,000 hypertensive patients from a larger dataset comprising 100,000 population size. Three hundred patients were examined for personalised BP control predictors who met the inclusion criteria of being treated for at least one year at the Hypertension and Research Centre in Rangpur, Bangladesh, between January 2020 and January 2021. BP control was assessed using World Health Organisation (WHO) and National Institute for Clinical Excellence (NICE) guidelines, and a comprehensive analysis of the sociodemographic and clinical variables was performed using multivariate logistic regression. Machine learning models such as K-Nearest Neighbours (KNN) were utilised to predict BP control with good performance using cross-validation techniques compared to other models. Explainable AI tools like Shapley Additive exPlanations (SHAP) and Local Interpretable Model-agnostic Explanations (LIME) provide interpretations of key variables with predictive qualities. Results: The mean age of participants was 49.37 ± 12.81 years, with 54.7% aged 40-59 years and 57.7% male. The overall BP control rate among the study population was 28%. Among those with controlled hypertension, 42% were rural residents ( Conclusion: The study elucidates critical gaps in hypertension management, emphasising the urgent need to address modifiable risk factors, tailor therapeutic regimens, and integrate socioeconomic considerations into public health frameworks. The findings advocate for scalable, data-driven interventions to bridge the hypertension care gap, thereby mitigating cardiovascular disease risks and enhancing health equity in underserved regions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.